LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Saved in:
Bibliographic Details
Title: LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.
Authors: Daldegan-Bueno D; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand. d.daldegan@auckland.ac.nz., Donegan CJ; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand., Forsyth A; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Sumner RL; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Murphy RJ; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Menkes DB; Department of Psychological Medicine, Waikato Clinical Campus, University of Auckland, Pembroke Street, Hamilton, 3240, New Zealand., Evans W; Mana Health, 7 Ruskin St, Parnell, Auckland, 1052, New Zealand., Hoeh N; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand., Sundram F; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand., Reynolds LM; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand., Ponton R; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Cavadino A; School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland, 1023, New Zealand., Smith T; Te Whatu Ora, Auckland, 1023, New Zealand., Roop P; Faculty of Engineering, University of Auckland, Auckland, 1023, New Zealand., Allen N; Faculty of Engineering, University of Auckland, Auckland, 1023, New Zealand., Abeysinghe B; Faculty of Engineering, University of Auckland, Auckland, 1023, New Zealand., Svirskis D; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Bansal M; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Muthukumaraswamy S; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand. sd.muthu@auckland.ac.nz.
Source: Trials [Trials] 2024 Aug 24; Vol. 25 (1), pp. 560. Date of Electronic Publication: 2024 Aug 24.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1745-6215
DOI:10.1186/s13063-024-08384-3